SaaS & Tech

By bringing algorithm-driven cost estimation and transparent clinical matching to an otherwise fragmented sector, CureMeAbroad is replacing legacy middlemen in the $174 billion medical tourism market.

By bringing a seasoned pharmaceutical executive onto its board, the makers of Claude are positioning themselves to navigate the heavily regulated life sciences sector and commercialize artificial intelligence in drug development.

The enterprise startup is aggressively moving beyond simple background checks into full-stack autonomous talent sourcing.

The transition of the massive ad account underscores a structural industry shift where enterprise clients are aggressively prioritizing proprietary data architecture over traditional agency relationships.

While the broader tech sector braces for automation-driven layoffs, Deloitte South Asia is pivoting toward complex problem-solving by training 30,000 existing employees and hiring 50,000 more to build its capability pipeline.

The Bengaluru-based social platform is consolidating the highly fragmented fandom economy, pulling Gen Z creators and audiences away from legacy forums into a single monetizable ecosystem.

The contract manufacturing giant aims to strengthen its balance sheet with a ₹500 crore pre-IPO bridge round while shifting revenue dependence toward high-margin aerospace and defense contracts.

Invest UP unilaterally terminated the massive artificial intelligence infrastructure agreement, citing the startup's critical lack of net worth and failure to establish credible financial linkages.

OpenAI has appointed former JioStar CEO Kiran Mani to a newly created role based in Singapore, signaling an aggressive push to capture the rapidly growing enterprise and consumer AI markets across India, Japan, and Southeast Asia.